Valneva SE ( INRLF) - Key Metrics
INRLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.18 | -$0.16 | -$0.10 | -$0.10 |
| 2026Q1 | $0.18 | -$0.19 | -$0.03 | -$0.03 |
| 2025Q4 | $0.27 | -$0.29 | -$0.14 | -$0.15 |
| 2025Q3 | $0.19 | -$0.29 | -$0.11 | -$0.12 |
| 2025Q2 | $0.31 | -$0.08 | -$0.02 | -$0.03 |
INRLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.37 |
| 2026Q1 | 0% | -3.56 |
| 2025Q4 | 0% | -3.08 |
| 2025Q3 | 0% | -4.03 |
| 2025Q2 | 0% | -8.73 |
INRLF
Price: $3.45
52 week price:
Earnings Per Share: -1.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 654.3 million